Literature DB >> 1628161

Platelet-activating factor (PAF) plays an important role in the immediate asthmatic response in guinea-pig by augmenting the response to histamine.

S Morooka1, M Uchida, N Imanishi.   

Abstract

1. To investigate the role of platelet activating factor (PAF) in the immediate asthmatic response, we examined the bronchial reactivity to histamine after administration of PAF to guinea-pigs or antigen challenge to passively sensitized guinea-pigs. 2. A bolus injection of PAF (20-40 ng kg-1), which did not cause a significant increase in intrathoracic pressure (ITP), augmented the bronchial response to histamine almost 8 fold. This airway hyperreactivity was observed even 1 min after PAF treatment. 3. A subthreshold dose of antigen (0.01 mg kg-1, i.v.) also provoked hyperreactivity to histamine, which became significant 6 and 11 min after the antigen treatment. 4. The specific PAF-antagonists, SM-10661 and CV-6209 (i.v.) dose-dependently inhibited both PAF- and antigen-induced airway hyperreactivities to histamine. 5. These results suggest that PAF plays an important role in antigen-induced acute airway responses by augmenting the activities of spasmogens.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1628161      PMCID: PMC1908441          DOI: 10.1111/j.1476-5381.1992.tb09051.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  Airway responses to histamine, acetylcholine, and propranolol in anaphylactic hypersensitivity in guinea pigs.

Authors:  V Popa; J S Douglas; A Bouhuys
Journal:  J Allergy Clin Immunol       Date:  1973-06       Impact factor: 10.793

2.  Allergen-induced increase in non-allergic bronchial reactivity.

Authors:  D W Cockcroft; R E Ruffin; J Dolovich; F E Hargreave
Journal:  Clin Allergy       Date:  1977-11

3.  Mechanism of perennial allergic asthma.

Authors:  D W Cockcroft
Journal:  Lancet       Date:  1983-07-30       Impact factor: 79.321

4.  Eosinophils, bronchial hyperreactivity and late-phase asthmatic reactions.

Authors:  S R Durham; A B Kay
Journal:  Clin Allergy       Date:  1985-09

5.  Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives.

Authors:  B B Vargaftig; J Lefort; M Chignard; J Benveniste
Journal:  Eur J Pharmacol       Date:  1980-07-25       Impact factor: 4.432

6.  The bronchoconstrictor properties of platelet-activating factor in humans.

Authors:  A H Rubin; L J Smith; R Patterson
Journal:  Am Rev Respir Dis       Date:  1987-11

7.  Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells.

Authors:  A G Stewart; P N Dubbin; T Harris; G J Dusting
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

8.  Prevention of non-specific airway hyperreactivity after allergen challenge in guinea-pigs by the PAF receptor antagonist SDZ 64-412.

Authors:  A M Havill; R G Van Valen; D A Handley
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

9.  Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes.

Authors:  S B Hwang
Journal:  J Biol Chem       Date:  1988-03-05       Impact factor: 5.157

10.  Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.

Authors:  J M Mencia-Huerta; R A Lewis; E Razin; K F Austen
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

View more
  5 in total

1.  Inhibition of leukotriene formation and IL-8 release by the paf-receptor antagonist SM-12502.

Authors:  R A Hilger; M Köller; W König
Journal:  Inflammation       Date:  1996-02       Impact factor: 4.092

2.  Effect of the PAF-receptor antagonist SM-12502 on human platelets.

Authors:  M Köller; R A Hilger; W König
Journal:  Inflammation       Date:  1996-02       Impact factor: 4.092

3.  Early bronchial hyperresponsiveness following injection of sephadex beads in the guinea pig: involvement of platelet activating factor and thromboxane A2.

Authors:  D M Conroy; P Sirois
Journal:  Inflammation       Date:  1999-10       Impact factor: 4.092

4.  Effects of CIS-19, a novel PAF receptor antagonist, on PAF-induced eosinophil recruitment and enhancement of superoxide anion generation in guinea-pigs.

Authors:  C M Teng; C H Lin; H P Kuo; F N Ko; H Ishii; T Ishikawa; I S Chen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

5.  Contribution of thromboxane A2 to the antigen-induced immediate asthmatic response mediated by IgG1 antibody by augmentation of bronchial responsiveness in guinea-pigs.

Authors:  A Arimura; F Asanuma; A Kurosawa; M Harada
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.